New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Accesswire
*IRVINE, CA / ACCESSWIRE / April 16, 2024 / *enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company..